{"id":90094,"topic":"peptides","source":"生物通","title":"小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究 - 生物通","url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","url_hash":"31f4b466ebfa9d14d8dfefd56399d40f08aab059","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMibEFVX3lxTE45OUlwRndXM2ZBV3ExQzNPaXd2dTdmc25XYmxnVjFsMWM2OVFTeHR6Um5nTjk2WG1iM1Z6WnlRYnZVdVNPdTltV0htU080YXhsRzFzbko2VjdQbDRzenNLUFdTN0F2akxTR1l1TA?oc=5\" target=\"_blank\">小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">生物通</font>","content":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","image_url":null,"lang":"zh","published_at":"2026-09-25T06:14:55+00:00","fetched_at":"2026-09-25T07:15:14+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 4055 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":4055,"summary_length":4055,"usable_text_length":4055,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":4055,"summary_length":4055}},"news_item":{"id":90094,"canonical_url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","source_url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","title":"小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究 - 生物通","source_name":"生物通","author":null,"published_at":"2026-09-25T06:14:55+00:00","locale":"zh","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMibEFVX3lxTE45OUlwRndXM2ZBV3ExQzNPaXd2dTdmc25XYmxnVjFsMWM2OVFTeHR6Um5nTjk2WG1iM1Z6WnlRYnZVdVNPdTltV0htU080YXhsRzFzbko2VjdQbDRzenNLUFdTN0F2akxTR1l1TA?oc=5\" target=\"_blank\">小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">生物通</font>","full_text":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","excerpt":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 4055 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 4055 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":4055,"summary_length":4055,"usable_text_length":4055,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":4055,"summary_length":4055}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究 - 生物通","url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","summary":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","source":"生物通","date":"2026-09-25T06:14:55+00:00","content":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 4055 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 4055 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":4055,"summary_length":4055,"usable_text_length":4055,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":4055,"summary_length":4055}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/90094","export_markdown":"/api/items/90094/export?format=markdown","export_json":"/api/items/90094/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.ebiotrade.com/newsf/2026-9/20260925091621501.htm"},"formats":{"full":{"id":90094,"title":"小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究 - 生物通","url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","source":"生物通","author":null,"published_at":"2026-09-25T06:14:55+00:00","locale":"zh","topic":"peptides","tags":[],"excerpt":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","full_text":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 4055 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 4055 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":4055,"summary_length":4055,"usable_text_length":4055,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":4055,"summary_length":4055}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 4055 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":4055,"summary_length":4055,"usable_text_length":4055,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":4055,"summary_length":4055}},"actions":{"read":"/item/90094","export_markdown":"/api/items/90094/export?format=markdown","export_json":"/api/items/90094/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.ebiotrade.com/newsf/2026-9/20260925091621501.htm"}},"digest":{"id":90094,"title":"小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究 - 生物通","url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","source":"生物通","topic":"peptides","published_at":"2026-09-25T06:14:55+00:00","excerpt":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization ±à¼ÍÆ¼ö£º…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 4055 characters.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究 - 生物通","subtitle":"生物通 · 2026-09-25","summary":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization ±à¼ÍÆ¼ö£º…","badges":["quality:high"],"links":{"read":"/item/90094","original":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","diagnose":"/api/diagnose?url=https%3A//www.ebiotrade.com/newsf/2026-9/20260925091621501.htm"},"quality_warning":null},"export":{"title":"小檗碱通过调控M2巨噬细胞极化预防和逆转胃痉挛多肽表达化生（SPEM）的机制研究 - 生物通","url":"https://www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","summary":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","source":"生物通","date":"2026-09-25T06:14:55+00:00","content":"¡¶International Journal of Molecular Sciences¡·£ºBerberine Prevents and Reverses Gastric Spasmolytic Polypeptide-Expressing Metaplasia by Modulating M2 Macrophage Polarization\n        \n        \t\n            \t±à¼ÍÆ¼ö£º\n                \n                ¡¡¡¡¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡\n                \n\t\t\t\t\n             \n            \n\t\t\t\n         \n        \n        ¡¡¡¡\n¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨SPEM£©ÊÇÒ»ÖÖ¹Ø¼üµÄÎ¸°©Ç°²¡±ä£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÒ©Àí¸ÉÔ¤´ëÊ©¡£Ð¡éÞ¼î£¨BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¾ßÓÐ¶àÐ§¿¹Ñ×ºÍ¿¹Ö×Áö»îÐÔ¡£±¾ÑÐ¾¿Ì½ÌÖÁËÐ¡éÞ¼îÊÇ·ñÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£²ÉÓÃËûÄªÎô·ÒÓÕµ¼µÄSPEMÐ¡ÊóÄ£ÐÍ£¬Í¨¹ý¿Ú·þ¹àÎ¸ÔÚÔ¤·À·½°¸ºÍÖÎÁÆ·½°¸ÖÐ¸øÓèÐ¡éÞ¼î¡£Í¨¹ýH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹âÆÀ¹ÀÎ¸ð¤Ä¤²¡ÀíÑ§¡£½øÐÐ×ªÂ¼×éÑ§·ÖÎö¡¢ÉúÎïÐÅÏ¢Ñ§·ÖÎöºÍµ¥Ï¸°ûRNA²âÐòÊý¾ÝÕûºÏÒÔÊ¶±ð¹Ø¼ü·Ö×Ó°Ðµã¡£Ð¡éÞ¼îÏÔÖø¼õÇáÁËËûÄªÎô·ÒÓÕµ¼µÄÎ¸ÏÙÌåÎ®Ëõ£¬¼ÓËÙÏÙÌå»Ö¸´£¬²¢¼õÉÙTFF2+ºÍAQP5+ SPEMÏ¸°ûµÄÊýÁ¿¡£×ªÂ¼×éÑ§·ÖÎöÏÔÊ¾£¬Ð¡éÞ¼îÄæ×ªÁËËûÄªÎô·ÒÓÕµ¼µÄJAK-STATºÍNF-¦ÊBÐÅºÅÍ¨Â·ÉÏµ÷¡£Ò»ÖÂµØ£¬Ð¡éÞ¼îÒÔÊ±¼äÒÀÀµÐÔ·½Ê½ÒÖÖÆCD163+ M2¾ÞÊÉÏ¸°û½þÈóÖÁÎ¸ð¤Ä¤¡£ÕûºÏµ¥Ï¸°û·ÖÎö¼ø¶¨³öS100A6±í´ïËæ¶ñÐÔ½øÕ¹Öð½¥Ôö¼Ó¡£S100A6ÔÚSPEMÖÐÒ²Éý¸ß£¬²¢ÔÚÐ¡éÞ¼îÖÎÁÆºóÏÂµ÷£¬Õâ¿ÉÄÜÓëM2¾ÞÊÉÏ¸°û½þÈóÏà¹Ø¡£Ð¡éÞ¼îÖÁÉÙ²¿·ÖÍ¨¹ýÒÖÖÆM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈóÀ´Ô¤·ÀºÍÄæ×ªÎ¸SPEM£¬¿ÉÄÜÍ¨¹ýµ÷½ÚJAK-STAT/NF-¦ÊBÍ¨Â·ºÍS100A6±í´ïÊµÏÖ¡£ÕâÐ©·¢ÏÖÎªÖ§³ÖÐ¡éÞ¼î×÷ÎªSPEMºòÑ¡ÖÎÁÆÒ©ÎïÌá¹©ÁËÁÙ´²Ç°Ö¤¾Ý¡£\nÎ¸°©£¨gastric cancer, GC£©ÊÇÈ«Çò°©Ö¢Ïà¹ØËÀÍöµÄÖ÷ÒªÔÒòÖ®Ò»£¬¶àÊý»¼ÕßÈ·ÕïÊ±ÒÑ´¦ÓÚÍíÆÚ¡£³¬¹ý80%µÄGCÎª³¦ÐÍGC£¬Æä·¢Õ¹×ñÑ¾µäµÄCorrea¼¶Áª£ºÂýÐÔÇ³±íÐÔÎ¸Ñ×¡úÂýÐÔÎ®ËõÐÔÎ¸Ñ×¡ú³¦»¯Éú¡úÒìÐÍÔöÉú¡ú°©±ä¡£½üÄêÀ´£¬¾·ÂÎ¶àëÄ±í´ï»¯Éú£¨spasmolytic polypeptide-expressing metaplasia, SPEM£©±»ÈÏÎªÊÇµÚ¶þÌõÇÒ¿ÉÄÜ¸üÔçµÄ»¯ÉúÍ¾¾¶£¬Æä±êÖ¾ÊÇÎ¸Ö÷Ï¸°û·¢ÉúÆ×ÏµÖØ±à³Ì£¬±í´ïTFF2ºÍAQP5µÈ·Ö×Ó±ê¼Ç¡£¼±ÐÔËðÉËÊ±SPEM²ÎÓëð¤Ä¤ÐÞ¸´£¬µ«ÔÚ³ÖÐøÑ×Ö¢´Ì¼¤ÏÂ¿ÉÄÜÆô¶¯°©Ç°²¡±ä½øÕ¹¡£»úÖÆÉÏ£¬M2¾ÞÊÉÏ¸°û¼«»¯Óë½þÈóÓÉIL-33-ST2-IL-13ÐÅºÅÖáÇý¶¯£¬¾ÞÊÉÏ¸°ûºÄ½ß¿ÉÈ¡ÏûSPEM£¬Í¹ÏÔÆäÔÚSPEM·¢²¡ÖÐµÄºËÐÄ×÷ÓÃ¡£ÁÙ´²ÉÏSPEMÔÚÔçÆÚÎ¸°©ÁÚ½üð¤Ä¤¼°ÄÚ¾µÇÐ³ýºó²ÐÎ¸ÖÐ¼ì³öÂÊ¸ß£¬ÇÒ²»Í¬ÓÚ³¦»¯Éú£¬SPEM¾ßÓÐ¿ÉÄæÐÔ£¬µ«Ä¿Ç°ÉÐÎÞÒ©Îï»ñÅúÓÃÓÚÔ¤·À»òÄæ×ªSPEM¡£Ð¡éÞ¼î£¨berberine, BBR£©ÊÇÒ»ÖÖÌìÈ»ÒìàßøÉúÎï¼î£¬¿ÉÍ¨¹ý¿¹Ñ×¡¢µ÷½ÚÏ¸°ûÖÜÆÚ¡¢×ÔÊÉÓëµòÍöµÈ¶àÐ§×÷ÓÃ¸ÉÔ¤Correa¼¶ÁªµÄ¶à¸ö²½Öè£¬µ«Æä¶ÔSPEMµÄ×÷ÓÃÉÐ²»Çå³þ¡£Òò´Ë£¬ÑÐ¾¿ÈËÔ±Ìá³ö¼ÙÉè£ºBBRÄÜ¹»Ô¤·ÀºÍ/»òÄæ×ªËûÄªÎô·ÒÓÕµ¼µÄÐ¡ÊóSPEM£¬²¢²ûÃ÷ÆäÇ±ÔÚ»úÖÆ¡£\nÑÐ¾¿ÈËÔ±²ÉÓÃËûÄªÎô·Ò£¨250 mg/kg£¬¸¹Ç»×¢Éä£¬3Ìì£©ÓÕµ¼SPEMÐ¡ÊóÄ£ÐÍ¡£Ô¤·À·½°¸ÎªBBR 100 mg/kg¿Ú·þ¹àÎ¸10Ìì£¨ÓÕµ¼Ç°7ÌìÖÁÓÕµ¼½áÊø£©£¬ÖÎÁÆ·½°¸ÎªSPEMÓÕµ¼ºó¸øÓèBBRÁ¬Ðø3¡¢7¡¢10»ò14Ìì¡£Í¨¹ý×éÖ¯²¡ÀíÑ§¡¢×ªÂ¼×éÑ§¼°ÕûºÏµ¥Ï¸°û·ÖÎö£¬ÑÐ¾¿ÈËÔ±Ö¤Ã÷BBRÄÜ¼õÇáSPEM£¬»úÖÆÉæ¼°ÒÖÖÆJAK-STAT/NF-¦ÊBÍ¨Â·¼°S100A6ÒÀÀµµÄM2¾ÞÊÉÏ¸°û¼«»¯ºÍ½þÈó¡£¸ÃÑÐ¾¿Ê×´ÎÖ¤ÊµBBR¶ÔSPEM¾ßÓÐÔ¤·ÀºÍÖÎÁÆ×÷ÓÃ£¬ÎªÁÙ´²Äæ×ªSPEM¼°×ÛºÏÔ¤·ÀGCÌá¹©ÁËÇ±ÔÚ²ßÂÔ¡£\nÖ÷Òª¼¼Êõ·½·¨°üÀ¨£ºÊ¹ÓÃSPF¼¶ÐÛÐÔC57BL/6Ð¡Êó£¨À´Ô´£º¿Õ¾ü¾üÒ½´óÑ§ÊµÑé¶¯ÎïÖÐÐÄ£¬Ðí¿ÉºÅSYXK[ÉÂÎ÷]2024-003£¬Â×ÀíÅú×¼ºÅ20250206£©£»Í¨¹ýËûÄªÎô·ÒÓÕµ¼SPEM£¬BBR¿Ú·þ¸ÉÔ¤£»²ÉÓÃH&EÈ¾É«¡¢ÃâÒß×éÖ¯»¯Ñ§ºÍÃâÒßÓ«¹â¼ì²âÎ¸ð¤Ä¤²¡Àí¼°TFF2¡¢ATP4¦Á¡¢AQP5¡¢CD163ºÍS100A6±í´ï£»ÀûÓÃRNA-seq½áºÏGene Ontology£¨GO£©¡¢KEGGºÍGene Set Enrichment Analysis£¨GSEA£©·ÖÎö²îÒì±í´ï»ùÒò£¨DEGs£©¼°Í¨Â·£»ÕûºÏ¹«¹²scRNA-seqÊý¾Ý£¨À´×ÔGEO£¬µÇÂ¼ºÅGSM3954949ºÍGSM4546323£¬º¬ÂýÐÔÎ®ËõÐÔÎ¸Ñ×[CAG]¡¢³¦»¯Éú[IM]ºÍGCÑù±¾£©ÒÔÉ¸Ñ¡½øÕ¹Ïà¹Ø»ùÒò¡£²âÐòÊý¾ÝÒÑ´æÈëSRAÊý¾Ý¿â£¨PRJNA1530028£©¡£\nÑÐ¾¿½á¹ûÈçÏÂ£º\n2.1 ¸ß¼ÁÁ¿ËûÄªÎô·Ò³É¹¦ÓÕµ¼SPEM¡£Í¨¹ýH&EÈ¾É«·¢ÏÖ£¬Ä£ÐÍ×éÎ¸ÏÙÌå½á¹¹ÎÉÂÒ¡¢Õý³£Ö±¹Ü×´½á¹¹É¥Ê§¡¢ÏÙÌåÓØÇúÀ©ÕÅ²¢ÐÎ³ÉÄÒÖ×£¬ÏÙÌå¸ß¶ÈÏÔÖø½µµÍ£¬ÖÐÏÙÇøÊÈËáÐÔ±ÚÏ¸°ûÃ÷ÏÔ¼õÉÙ¡£ÃâÒß×é»¯ºÍÃâÒßÓ«¹âÏÔÊ¾ATP4¦Á\n+±ÚÏ¸°ûÏÔÖø¼õÉÙ£¬¶øTFF2\n+ºÍAQP5\n+Ï¸°ûÔÚÏÙ»ù²¿ÏÔÖøÔö¼Ó£¬Ö¤ÊµSPEMÄ£ÐÍ½¨Á¢³É¹¦¡£\n2.2 Ô¤·ÀÐÔÐ¡éÞ¼î¼õÇáSPEM¡£H&EÏÔÊ¾Ô¤·ÀÐÔBBRÎ´ÍêÈ«»Ö¸´Õý³£µÄÏÙÌå½á¹¹£¬µ«ÏÔÖøÔö¼ÓÏÙÌå¸ß¶È²¢±£ÁôÖÐÏÙÇø±ÚÏ¸°ûÊýÁ¿£»ÃâÒß×é»¯ÓëÃâÒßÓ«¹â½øÒ»²½Ö¤ÊµATP4¦Á\n+±ÚÏ¸°ûÏÔÖøÔö¼Ó£¬AQP5\n+Ï¸°ûÏÔÖø¼õÉÙ£¬TFF2\n+Ï¸°û³ÊÏÂ½µÇ÷ÊÆµ«Î´´ïÍ³¼ÆÑ§ÒâÒå¡£Õâ±íÃ÷BBRÍ¨¹ý¼õÇá±ÚÏ¸°û¶ªÊ§²¿·ÖÔ¤·ÀÁËSPEM¡£\n2.3 ÖÎÁÆÐÔÐ¡éÞ¼î¼ÓËÙSPEMÏûÍË¡£ÔÚSPEMÓÕµ¼ºó¸øÓèBBR£¬µÚ3¡¢7¡¢10ÌìÊ±ÏÙÌå¸ß¶ÈÏÔÖø¸ßÓÚÊ±¼äÆ¥ÅäµÄ¶ÔÕÕ×é£»BBR×éµÚ10ÌìµÄÏÙÌå¸ß¶ÈÒÑÏàµ±ÓÚ¶ÔÕÕ×éµÚ14ÌìµÄË®Æ½£¬ÇÒATP4¦Á\n+","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.ebiotrade.com/newsf/2026-9/20260925091621501.htm","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 4055 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 4055 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":4055,"summary_length":4055,"usable_text_length":4055,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":4055,"summary_length":4055}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}